Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
  2. >
  3. Earnings
  4. >
  5. Procter Gamble Reports First Quarter Fiscal 2025 Financial Results
PG.N

Procter Gamble Reports First Quarter Fiscal 2025 Financial Results

2024-10-183mins
Content

The Procter & Gamble Company (NYSE: PG) has announced its financial results for the first quarter of fiscal year 2025, concluding in September 2024. The report outlines minor contractions in net sales alongside a stable trajectory in core financial metrics despite challenging global economic conditions.

Key Financial Metrics

Metric Current Quarter Previous Year Year-over-Year Change Consensus Estimates
Net Sales $21.7 billion $21.9 billion -1% $21.91 billion
Organic Sales Growth +2% +7% (base period) N/A N/A
Diluted EPS $1.61 $1.83 -12% N/A
Core EPS $1.93 $1.84 +5% $1.9

Procter & Gamble's first-quarter net sales declined by one percent to $21.7 billion, marginally below Wall Street expectations of $21.91 billion. However, core EPS came in at $1.93, surpassing the consensus estimate of $1.9, reflecting a 5% increase. The company faced a decline in diluted EPS primarily due to increased restructuring charges.

Segment Revenue Performance

Segment Organic Sales Growth Comments
Beauty -2% Driven by a decline in Skin Care sales
Grooming +3% Driven by innovation-related volume growth
Health Care +4% Boosted by oral care mix and pricing increases
Fabric and Home Care +3% Positive geographical mix influence
Baby, Feminine, and Family Care 0% Mixed performance across sub-categories

Procter & Gamble experienced a mixed performance across its segments. Notable was the decline in the Beauty segment due to lower SK-II brand sales, contrasted by growth in Grooming and Fabric and Home Care segments driven by innovation and favorable product mixes.

advertising space image advertising space image

Key Developments

  • Completed a limited market portfolio restructuring, notably with substantial liquidation in Argentina.
  • Operating cash flow was at $4.3 billion with adjusted free cash flow productivity in line with expectations at 82%.
  • The company returned $4.4 billion to shareholders through dividends and share repurchases.

Executive Commentary

Chairman and CEO Jon Moeller emphasized the company's commitment to its growth strategy, focusing on a portfolio of daily-use categories. Moeller highlighted the company's strategic pillars as key drivers of continued balanced growth and value despite macroeconomic pressures.

Dividends and Share Repurchase Program

P&G reported returning nearly $4.4 billion to shareholders, with over $2.4 billion in dividends and $1.9 billion in share repurchases during the quarter.

Forward Guidance

Procter & Gamble maintained its guidance for fiscal 2025, forecasting all-in sales growth of two to four percent and organic sales growth of three to five percent. The company anticipates core earnings per share growth of five to seven percent, projecting a mid-point EPS of $6.98 for the fiscal year.

Stock Movement

Following the earnings announcement, Procter & Gamble's stock experienced a slight decline, with a 0.0017% decrease in its share price.

This earnings release presents a portrait of resilient financial health amid global challenges, with strategic initiatives in place to sustain long-term growth and shareholder value.

For more in-depth analysis and insights, stay tuned with our platform to stay ahead of the market.

FAQ

arrow icon

arrow icon

arrow icon

arrow icon

arrow icon

background

Outsmart the Market
with Artificial
Intelligence

The most powerful Al stock
analysis & suggestions tool
in the world

Share

Want more financial insights delivered directly to your inbox?

Subscribe now and receive handpicked financial news, insights, and trending topics.

ASND.O
Ascendis Pharma A/S Posts Strong Q3 Growth- Intellectia AI™
Intellectia.AI5 hours ago
CSCO.O
Cisco Systems Q1 2026 Earnings: Robust Growth Insights- Intellectia AI™
Intellectia.AI5 hours ago
TDG.N
TransDigm Group Inc Q4 2025 Earnings Rise 30%- Intellectia AI™
Intellectia.AI14 hours ago
LEGN.O
Legend Biotech Earnings: CARVYKTI® Drives Growth- Intellectia AI™
Intellectia.AI14 hours ago

Share

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto Tracker
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free